13 results
8-K
EX-10.1
KA
Kineta Inc
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
physically injured or destroyed; and defense costs, charges and expenses incurred in the investigation, adjustment or defense of claims
S-4
EX-10.18
KA
Kineta Inc
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
that has not been physically injured or destroyed; and defense costs, charges and expenses incurred in the investigation, adjustment or defense of claims
8-K
EX-99.6
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
is liable to provide ‘no fault’ compensation to any study subject injured in the clinical trial.
Prior to commencing a clinical trial, the sponsor
8-K
EX-99.5
bop64qzkn2kuia
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
c0an5l15v3sq2w
10 Nov 22
Prospectus supplement
4:21pm
- Prev
- 1
- Next